Nicotine use disorder and Neuregulin 3: Opportunities for precision medicine

Adv Pharmacol. 2024;99:387-404. doi: 10.1016/bs.apha.2023.10.001. Epub 2024 Feb 9.ABSTRACTNicotine use disorder remains a major public health emergency despite years of trumpeting the consequences of smoking. This is likely due to the complex interplay of genetics and nicotine exposure across the lifespan of these individuals. Genetics influence all aspects of life, including complex disorders such as nicotine use disorder. This review first highlights the critical neurocircuitry underlying nicotine dependence and withdrawal, and then describes the cellular signaling mechanisms involved. Finally, current genetic, genomic, and transcriptomic evidence for new drug development of smoking cessation aids is discussed, with a focus on the Neuregulin 3 Signaling Pathway.PMID:38467488 | DOI:10.1016/bs.apha.2023.10.001
Source: Advances in Pharmacology - Category: Drugs & Pharmacology Authors: Source Type: research